CHRNA1 Gene Myasthenic Syndrome Congenital Fast Channel Genetic Test
Introduction
The CHRNA1 gene is associated with a genetic disorder called congenital myasthenic syndrome (CMS) with a fast channel defect. This disorder affects the neuromuscular junction, leading to muscle weakness and fatigue.
NGS Technology
NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology used to analyze multiple genes simultaneously. In the case of CMS with a fast channel defect, NGS genetic testing can be used to identify mutations or variations in the CHRNA1 gene that may be responsible for the disorder.
Test Details
The CHRNA1 Gene Myasthenic Syndrome Congenital Fast Channel Genetic Test is a Neurological Disorders test offered by DNA Labs UAE. The test is performed using NGS technology in the Genetics department.
Test Name:
CHRNA1 Gene Myasthenic Syndrome Congenital Fast Channel Genetic Test
Components:
- Price: 4400.0 AED
Sample Condition:
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery:
3 to 4 Weeks
Method:
NGS Technology
Test Type:
Neurological Disorders
Doctor:
Neurologist
Pre Test Information:
Clinical History of Patient who is going for CHRNA1 Gene Myasthenic Syndrome Congenital Fast Channel Genetic Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA1 Gene Myasthenic Syndrome Congenital Fast Channel.
Test Benefits:
- Confirm the diagnosis of CMS with a fast channel defect
- Provide information about the specific genetic variations present in an individual
- Guide treatment decisions
- Provide information about the inheritance pattern of the disorder
- Contribute to research efforts aimed at developing targeted therapies for CMS with a fast channel defect
| Test Name | CHRNA1 Gene Myasthenic syndrome congenital fast channel Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CHRNA1 Gene Myasthenic syndrome, congenital, fast channel NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CHRNA1 Gene Myasthenic syndrome, congenital, fast channel |
| Test Details |
The CHRNA1 gene is associated with a genetic disorder called congenital myasthenic syndrome (CMS) with a fast channel defect. This disorder affects the neuromuscular junction, leading to muscle weakness and fatigue. NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology used to analyze multiple genes simultaneously. In the case of CMS with a fast channel defect, NGS genetic testing can be used to identify mutations or variations in the CHRNA1 gene that may be responsible for the disorder. NGS genetic testing involves sequencing the DNA of an individual to identify any changes or mutations in the CHRNA1 gene. This can help in confirming the diagnosis of CMS with a fast channel defect and can also provide information about the specific genetic variations present in an individual. The results of NGS genetic testing can be used for genetic counseling, providing information about the inheritance pattern of the disorder, and guiding treatment decisions. It can also help in understanding the underlying molecular mechanisms of the disorder and contribute to research efforts aimed at developing targeted therapies for CMS with a fast channel defect. |
